Drugs / chitooligosaccharide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00468962 | — | — | Eulji University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | chitooligosaccharide | “In the present study, we prepared a chitooligosaccharide with high absorbability and evaluated its effects on activation of immune function and cardiovascular funciton(lipid,...” NCT00468962 ↗ |
| Known as | FACOSTM | “half dose chitooligosaccaride(FACOSTM) intake group(n=10)” NCT00468962 ↗ |